Showing results (41-50 of 224) with videos related to
Sort By:
Pageof 23
Clinical and Experimental Rheumatology|November 7, 2001
COX-2 inhibitors and the cardiovascular systemG A FitzGerald, Y Cheng, S AustinProstaglandins|May 1, 1987
Prostacyclin as neuromodulator in the sympathetically stimulated rabbit heartM Wennmalm, G A FitzGerald, A WennmalmFederation Proceedings|January 1, 1987
Thromboxane A2 biosynthesis in human diseaseG A FitzGerald, C Healy, J DaughertyClinical Pharmacology and Therapeutics|August 1, 1981
Norepinephrine release in essential hypertensionG A FitzGerald, V Hossmann, C T DolleryEicosanoids|January 1, 1992
Thromboxane synthase inhibition in allergen challenged sheep lung: effect on eicosanoid synthesisR Dworski, G A FitzGerald, J R ShellerThe Journal of Clinical Investigation|November 1, 1988
Prostaglandin endoperoxides modulate the response to thromboxane synthase inhibition during coronary thrombosisD J Fitzgerald, J Fragetta, G A FitzGeraldHypertension (Dallas, Tex. : 1979)|January 1, 1981
Influence of hospitalization and placebo therapy on blood pressure and sympathetic function in essential hypertensionV Hossmann, G A FitzGerald, C T DolleryBlood|March 15, 1992
Inhibition of clot lysis and decreased binding of tissue-type plasminogen activator as a consequence of clot retractionS Kunitada, G A FitzGerald, D J FitzgeraldProceedings of the National Academy of Sciences of the United States of America|August 1, 1990
Molecular cloning, primary structure, and expression of the human platelet/erythroleukemia cell 12-lipoxygenaseC D Funk, L Furci, G A FitzGeraldCirculation Research|July 1, 1989
Increased thromboxane biosynthesis during coronary thrombolysis. Evidence that platelet activation and thromboxane A2 modulate the response to tissue-type plasminogen activator in vivoD J Fitzgerald, F Wright, G A FitzGeraldPageof 23